TNSr did not reach statistical significance between groups; only clinical muscle strength showed pronounced weakness in the combined protocol ( P <0.05).
← all excerpts
Chemotherapy-Induced Peripheral Neuropathy (CIPN) in Patients Receiving 4-6 Cycles of Platinum-Based and Taxane-Based Chemotherapy: A Prospective, Single-Center Study from Kosovo.
1
0.0500
0.0500